Scinovex
article Open AccessTop 1% cited

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

The Lancet Oncology · 2010 · Vol. 11(10) · pp. 927–933
David N. KragStewart AndersonThomas B. JulianAnn BrownSeth P. HarlowJoseph P. CostantinoTakamaru AshikagaDonald L. WeaverEleftherios P. MamounasLynne M JalovecThomas G. FrazierR. Dirk NoyesAndré RobidouxHugh MC ScarthNorman Wolmark
Breast Cancer Treatment StudiesBreast Lesions and CarcinomasBreast Implant and ReconstructionMedicineAxillary Lymph Node DissectionSentinel lymph nodeBreast cancerLumpectomyMastectomySurgeryAxillaSentinel nodeLymph node

MeSH terms

AxillaBreast NeoplasmsCanadaColoring AgentsFemaleHumansLymph Node ExcisionLymphatic MetastasisMiddle AgedNeoplasm Recurrence, LocalRisk FactorsRosaniline DyesTechnetium Tc 99m Sulfur ColloidTime FactorsUnited States
Citations
1,892
FWCI
33.56
field-weighted impact
References
36
Percentile
100%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.